/

Scientific Animation

Scientific Animation: Chicken Embryo Development

Created for Australian Poultry CRC

axs-studio-scientific-animation-chicken-embryo-development-04-drv

Chick in egg. © 2015 AXS Studio Inc. All Rights Reserved.

axs-studio-scientific-animation-chicken-embryo-development-03

Beak development in chick embryo. © 2015 AXS Studio Inc. All Rights Reserved.

axs-studio-scientific-animation-chicken-embryo-development-02

Embryonic development of chick © 2015 AXS Studio Inc. All Rights Reserved.

axs-studio-scientific-animation-chicken-embryo-development-01

Embryonic development of chick, with yolk sack © 2015 AXS Studio Inc. All Rights Reserved.

The project

Commissioned for outreach & education, this scientific animation details the 21-day development of a chick embryo and adheres to the Australian national science curriculum: life cycles & comparative embryology. Informed by detailed research, 7 3D models were created to represent the chick at key stages of growth. This scientific animation has been used widely in classrooms — a primary goal of the project. 6,000,000+ YouTube views.

Created for
Australian Poultry CRC

More

Scientific Animation

Title screen from XL309 MOA animation. SL is an emerging strategy for targeting cancer cells. Our client’s lead SL candidate, XL309, inhibits USP1, a deubiquitinase essential for single-strand DNA break repair. Due to compensatory DNA repair mechanisms, XL309 has no effect on healthy cells. However, XL309 is lethal in cancers with homologous recombination (HR)-deficiency that have genetic alterations impairing double-strand DNA break repair. To explain this complex story to multiple audiences, we created a clear, concise MOA animation. Flowchart-like 3D motion graphics make it easy to follow the complex interplay of DNA damage repair mechanisms, while molecular scenes illustrate how the different proteins interact to orchestrate DNA repair.

Synthetic lethality (SL) Mechanism of Action (MOA) Animation

Exelixis, Inc.

axs-studio-medical-animation-cancer-moa-xb002-01

Medical Animation: Cancer ADC MOA

Exelixis, Inc.

Still image of the CMB complex from a cancer pathway MOD/MOA animation.

Medical Animation: Cancer Small Molecule MOA

Exelixis, Inc.

Still image from the Certepetide MOA animation showing a solid tumor growing.

Scientific Animation: Certepetide MOA

Lisata Therapeutics

Title slide from zanzalintinib (XL092) mechanism of action (MOA) animation. XL092 is a small-molecule inhibitor of multiple receptor tyrosine kinases (RTKs) that are involved in cancer growth and immune regulation. Animation is divided into chapters. A web-based interactive version of the video was developed for use at congresses. Animation launched at AACR 2022.

Oncology MOD and MOA Animation

Exelixis, Inc

axs-studio-scientific-animation-cytoplasm-mitochondria

Scientific Animation - Photobiomodulation Therapy for AMD

LumiThera, Inc.

axs-studio-medical-animation-science-of-heptalin-01

Medical Animation: The Science of Hepatalin

Scimar Ltd.

axs-studio-scientific-animation-agritech-04

Agricultural Biotechnology Animation

Azotic Technologies Ltd

axs-studio-scientific-animation-SARS-CoV2-diagnostic-02

VITROS SARS-CoV-2 Diagnostic Scientific Animation

Ortho Clinical Diagnostics

axs-studio-scientific-animation-SARS-CoV2-COVID19-01

Biology of SARS-CoV-2 Scientific Animations

HHMI BioInteractive

axs-studio-medical-animation-mulitple-myeloma-proteasome

Medical Animation: Proteasome in Multiple Myeloma

Biopharmaceutical client

axs-studio-scientific-animation-gene-doctors-dna-02-drv-nolabel

Medical Animation: The Gene Doctors

Tangled Bank Studios, HHMI